中文 | English
Return
Total: 98 , 1/10
Show Home Prev Next End page: GO
Author:( Kexin XU)

1.Identification of low-molecular weight prostate-specific antigen(PSA) and lactoferrin in the prostatic secretion of benign prostatic hyperplasia

Kexin XU ; Xiaofeng WANG

Journal of Peking University(Health Sciences) 2003;0(06):-

2.Expression of MMP-2, MMP-9, TIMP-2 in bladder carcinoma as a prognostic marker

Kexin XU ; Shukun HOU ; Zhijun DU

Chinese Journal of Urology 2001;0(04):-

3.Urine nuclear matrix protein 22 and bladder tumor antigen test in the screening of bladder tumor recurrence

Kexin XU ; Shukun HOU ; Xiaofeng WANG

Chinese Journal of Urology 1994;0(02):-

4.Survey of the management of benign prostatic hyperplasia by Chinese urologists

Shaogang WANG ; Zhangqun YE ; Kexin XU ; Jianbin BI ; Chuanliang XU

Chinese Journal of Urology 2015;36(1):44-49

5.The effect of RNA interference induced by inhibition of hTERT and Bi-1 gene expression

Huimin WANG ; Kexin HE ; Jianhua XU ; Chenyu SHANG ; Keyuan ZHOU

Chongqing Medicine 2015;(8):1012-1016

6.Design of a filtering circuitfor acquiring ECG signals

Haifeng WU ; Feng XU ; Yi CAO ; Kexin ZHANG

Chinese Medical Equipment Journal 2003;0(12):-

7.Capability of SMBG instrument and its progress

Haitao TANG ; Yi WANG ; Qilian YU ; Kexin XU

Chinese Medical Equipment Journal 2004;0(09):-

8.Expressions of MAD2 and p55CDC in prostate cancer and their correlations with the prostate cancer grading

Kexin XU ; Xianghong WANG ; Weicheng XUE ; Xiaofeng WANG ; Shuku HOU

Journal of Peking University(Health Sciences) 2003;0(06):-

9.The role of TURP in the management of prostate carcinoma

Xiaodong ZHANG ; Kexin XU ; Xiaofeng WANG ; Shukun HOU

Chinese Journal of Urology 2000;0(05):-

10.Surgical treatment for epididymal obstructive azoospermia

Guoxi ZHANG ; Xiaofeng WANG ; Wenjun BAI ; Kexin XU

Chinese Journal of Urology 2010;31(11):782-785

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 98 , 1/10 Show Home Prev Next End page: GO